Manuscript Submission Guidelines: The Canadian Journal of Psychiatry (The CJP)
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/cjp to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of The CJP will be reviewed.
SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
1. What do we publish?
1.1 Aims & Scope
Established in 1956, The Canadian Journal of Psychiatry has been keeping psychiatrists up- to-date on the latest research for over 60 years. The Canadian Journal of Psychiatry provides a forum for psychiatry and mental health professionals to share their findings with more than 3000 researchers and clinicians.
The Canadian Journal of Psychiatry includes peer-reviewed scientific articles analyzing ongoing developments in Canadian and international psychiatry. Regular features include:
• The popular "In Review" series, written by world leaders in psychiatric research on a broad range of biopsychological topics;
• Perspectives articles that take evidence-based sides on controversial, complex, or emerging themes;
• The latest Original Research and Systematic Review papers;
• Research Letters which briefly communicate research findings;
• Letters to the Editor;
• Official Position Papers, Policy Statements, and Clinical Practice Guidelines of the Canadian Psychiatric Association; and
• Supplements
1.2 Article types
The following describes the manuscript (MS) types published in The CJP, including requirements for each, such as word count (not including structured abstracts, acknowledgements, references, tables, and figures) and number of tables and figures. These restrictions are enforced to enable The CJP to publish as many papers in each issue as possible.
Please ensure that you are using Times New Roman or a similar font and double-spaced line formatting.
Research Article Type Description Requirements
Original Research
Includes research findings of substantive original research studies (eg. clinical research, epidemiological studies, genetic studies, imaging, cohort studies, meta-analysis, mega-
analysis, etc)
• 3,500 words
• ≤300-word structured abstract
• ≤5 figures and tables,
combined
• ≤70 references
Clinical Trial
Research study which assigns subjects to intervention (eg. drugs, psychological treatments, nutraceuticals, dietary supplements etc) or control condition to assess the effects of intervention on clinical outcomes. The study must have been registered with clinical trials.gov or similar online clinical registry.
• 3,500 words
• ≤300-word structured abstract
• Must include a CONSORT diagram, may include an additional 5 tables/figures
• CONSORT checklist
• Include Trial Registration details and ID in the methods
• ≤70 references
Research Letter
Research findings of novel, pilot, and proof of concept studies for rapid review and publication.
• ≤800 words
• 1 table or figure
• ≤5 references
• No abstract
Clinical Review and Education Article Type Description Requirements
Systematic or Scoping Reviews
Systematic search and critical assessment of the literature with or without quantitative analysis (meta- analysis or mega-analysis)
• 5,000 words
• ≤300-word structured abstract
• ≤5 figures and tables, combined
• ≤70 references
• Follow PRISMA checklist
• Include PRISMA flow sheet as a figure
Commentary
Commentaries can be related to published articles. Invited commentaries are any manuscripts covering any contemporary or controversial areas.
• ≤1,200 words
• No abstract required
• ≤9 references
• Perspective or In Review article (to which commentary is related) is cited in the commentary text and added to the reference list
In Review
Published by invitation ONLY. The Editor-In-Chief invites experts in the field to write state-of-the-art reviews for publication.
Unsolicited manuscripts are not accepted.
• 3,500 words
• ≤300-word structured abstract
• ≤5 tables and/or figures
• ≤100 references
Updated and authoritative statement about an area of psychiatry.
• May be accompanied by an invited commentary of ≤1,200 words
Opinion Article Type Description Requirements
Perspective
Brief articles covering emerging, contentious, or complex themes relevant to the journal’s mandate.
By invitation only, but authors are encouraged to contact the Editor-in-Chief if they have ideas for a Perspective article.
MSs not expected to provide comprehensive coverage of existing literature. Instead, MSs may adopt a specific perspective
on a contemporary problem or issue.
• 2,500 words
• No abstract required
• ≤1 table or figure
• ≤30 references
• May be accompanied by an invited commentary of approx. 1,200 words
Letter to the Editor
Must be related to The CJP- published articles.
Once accepted, the Editorial Office will contact the corresponding author of the article in question to reply.
Letter and reply will be published together.
• Submitted within 4 months of original publication
• Descriptive title
• ≤500 words for body
• No tables and figures
• ≤5 references
The CJP does not publish clinical trial protocols, case reports or book reviews.
1.3 Writing your paper
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
See 4. Preparing your manuscript for submission for section specific information.
1.3.1 Make your article discoverable
When writing your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as
Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online
2. Editorial policies
2.1 Peer review policy
The CJP recognizes the value and importance of peer review in maintaining the integrity of the scientific record. The peer review process is essential to scholarly publication both as a critique and a collaboration to improve the quality of the manuscript.
The CJP operates a conventional single-blind reviewing policy in which the reviewers’ names are always concealed from the submitting author(s).
Additional Information
All manuscripts are reviewed initially by the Editors and only those papers that meet the scientific and editorial standards of the journal and fit within the aims and scope of the journal, will be sent for outside review.
Decisions on manuscripts will be made as rapidly as possible. Authors should expect to receive reviewer comments within approximately 6 weeks. In general, Editors will seek advice from three or more expert reviewers about the scientific content and presentation of submitted articles.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
Publons
Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for The CJP can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s recommendation, and the content of their review is not published on the site. For more information, visit the Publons website.
2.2 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors. The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
2.3 Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support. If a personal communication is referenced in the MS (as a parenthetical statement, not in the reference list), the Acknowledgements section should include a statement that the person quoted gave permission for the information to be used. A copy of the email or letter granting permission should be sent to the Editorial Office for its records.
2.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
2.4 Declaration of conflicting interests
The CJP requires authors to include a declaration of any conflicting interests and recommends you review the good practice guidelines on the SAGE Journal Author Gateway
It is our policy to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations here.
2.5 Funding
The CJP requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Funding from both public and private sources should be acknowledged,
including grant numbers if available, or if there was no funding state that: This research received no specific grant from any funding agency in the public, commercial, or not-for- profit sectors.
2.6 Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal. Information on informed consent to report individual cases or case series should be included in the manuscript text.
In terms of patient privacy, authors are required to follow the ICMJE Recommendations for the Protection of Research Participants. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published, and the written consent should be included with the manuscript files.
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
2.7 Clinical trials
The CJP conforms to the ICMJE requirement that clinical trials are registered in a WHO- approved public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The registry must meet several criteria, including: being accessible to the public at no charge; being open to all prospective registrants; being managed by a not-for-profit organization; having a mechanism to ensure the validity of the registration data; and being electronically searchable. Examples include http://clinicaltrials.gov and http://www.who.int/ictrp/network/primary/en/index.html. The registration name and number should be listed at the end of the Abstract.
While trial methodology must be registered, trial results need not be registered. Should the authors decide to register the results, they must be registered in the same registry as the initial methodology to be considered previously unpublished.
The International Committee of Medical Journal Editors defines a clinical trial as any research project that prospectively assigns people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioural treatments, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.
2.8 Reporting guidelines
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
……
更多详情：
https://journals.sagepub.com/pb-assets/cmscontent/cpa/CJP%20Submission%20Checklist%20rev%20061721-1624635234.pdf
